200 related articles for article (PubMed ID: 2808202)
21. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Hikida M; Itahashi K; Igarashi A; Shiba T; Kitamura M
Antimicrob Agents Chemother; 1999 Aug; 43(8):2010-6. PubMed ID: 10428928
[TBL] [Abstract][Full Text] [Related]
22. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
[TBL] [Abstract][Full Text] [Related]
24. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.
King A; Boothman C; Phillips I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():31-45. PubMed ID: 2808214
[TBL] [Abstract][Full Text] [Related]
25. Binding of beta-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus.
Chambers HF; Sachdeva M
J Infect Dis; 1990 Jun; 161(6):1170-6. PubMed ID: 2345297
[TBL] [Abstract][Full Text] [Related]
26. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus.
Franciolli M; Bille J; Glauser MP; Moreillon P
J Infect Dis; 1991 Mar; 163(3):514-23. PubMed ID: 1995724
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa.
Fung-Tomc JC; Huczko E; Banville J; Ménard M; Kolek B; Gradelski E; Kessler RE; Bonner DP
Antimicrob Agents Chemother; 1995 Feb; 39(2):394-9. PubMed ID: 7726504
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
Gootz T; Retsema J; Girard A; Hamanaka E; Anderson M; Sokolowski S
Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.
Fujimura T; Yamano Y; Yoshida I; Shimada J; Kuwahara S
Antimicrob Agents Chemother; 2003 Mar; 47(3):923-31. PubMed ID: 12604523
[TBL] [Abstract][Full Text] [Related]
30. Affinities of BO-2727 for bacterial penicillin-binding proteins and morphological change of gram-negative rods.
Hashizume T; Nakamura K; Nakagawa S
J Antibiot (Tokyo); 1997 Feb; 50(2):139-42. PubMed ID: 9099223
[TBL] [Abstract][Full Text] [Related]
31. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
[TBL] [Abstract][Full Text] [Related]
32. Bactericidal activity of meropenem and interactions with other antibiotics.
Ferrara A; Grassi G; Grassi FA; Piccioni PD; Gialdroni Grassi G
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():239-50. PubMed ID: 2808210
[TBL] [Abstract][Full Text] [Related]
33. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution.
Grayson ML; Eliopoulos GM; Wennersten CB; Ruoff KL; De Girolami PC; Ferraro MJ; Moellering RC
Antimicrob Agents Chemother; 1991 Nov; 35(11):2180-4. PubMed ID: 1803989
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic resistance in gram-positive bacteria: epidemiological aspects.
Witte W
J Antimicrob Chemother; 1999 Sep; 44 Suppl A():1-9. PubMed ID: 10511391
[TBL] [Abstract][Full Text] [Related]
35. Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.
Fung-Tomc JC; Gradelski E; Kolek B; Minassian B; Pucci M; Kessler RE; Bonner DP
Antimicrob Agents Chemother; 1995 Feb; 39(2):386-93. PubMed ID: 7726503
[TBL] [Abstract][Full Text] [Related]
36. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Chambers HF; Sachdeva M; Kennedy S
J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
[TBL] [Abstract][Full Text] [Related]
37. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
[TBL] [Abstract][Full Text] [Related]
38. Terminology of Staphylococcus aureus strains showing decreased susceptibility to methicillin.
Smith JM
J Antimicrob Chemother; 1992 Feb; 29(2):219-21. PubMed ID: 1506337
[No Abstract] [Full Text] [Related]
39. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Que YA; Entenza JM; Francioli P; Moreillon P
J Infect Dis; 1998 Jan; 177(1):146-54. PubMed ID: 9419181
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
Williams RJ; Yang YJ; Livermore DM
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
